Quantum Biosystems Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Quantum Biosystems General Information

Description

Developer of quantum mechanics systems designed to provide assistance in the development of innovative single-molecule DNA sequencers. The company's systems offer a sequencing system that gathers genetic data with broad applicability through accelerated use of DNA and RNA sequencing, enabling clients to unlock genetically modified codes with physics, thereby promoting development in their research.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 5-8-3 Nishinakajima, Yodogawa-ku
  • Shin-Osaka Sun R North Building, Room 601
  • Osaka, 532-0001
  • Japan

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quantum Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 10-Jan-2022 000.00 Completed Out of Business
7. Later Stage VC (Series C2) 30-Nov-2018 00.000 000.00 000.00 Completed Generating Revenue
6. Accelerator/Incubator 11-Jun-2018 000.00 Completed Generating Revenue
5. Later Stage VC (Series C) 09-Feb-2015 000.00 000.00 000.00 Completed Generating Revenue
4. Grant 17-Dec-2014 000.00 00.000 Completed Generating Revenue
3. Early Stage VC (Series B) 19-Feb-2014 00.00 00.000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 29-Apr-2013 $1.33M $1.33M 00.000 Completed Startup
1. Spin-Off 07-Jan-2013 Completed Startup
To view Quantum Biosystems’s complete valuation and funding history, request access »

Quantum Biosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class C2 Preferred 0,000,000 00.0 00.0 00 00.0 00.000
Series C 0,000,000 00.0 00.0 00 00.0 00.000
Series B 1,500,000 $2.65 $2.65 1x $2.65 12.88%
Series A 1,300,000 $0.88 $0.88 1x $0.88 11.17%
To view Quantum Biosystems’s complete cap table history, request access »

Quantum Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of quantum mechanics systems designed to provide assistance in the development of innovative single-molecule D
Biotechnology
Osaka, Japan
000.00
00000000 00 000.00

000000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
0000000000000
Baltimore, MD
000 As of 0000
00000
00000 0000-00-00
000000&0 00000

000000

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in rep
0000000000000
Seraing, Belgium
000 As of 0000
00.000
00000 0000-00-00
000000&0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quantum Biosystems Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD 000 00000 000000&0 00000
Diagenode Formerly VC-backed Seraing, Belgium 000 00.000 000000&0 00.000
Cellecta Private Debt Financed Mountain View, CA 00 000000000 -
Bionano Formerly VC-backed San Diego, CA 000 00000 00000000 00000
Quantapore Venture Capital-Backed South San Francisco, CA 00 000.00 000000 - 000 000.00
You’re viewing 5 of 33 competitors. Get the full list »

Quantum Biosystems Patents

Quantum Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210238672-A1 Systems and methods for detection of biomolecules Inactive 18-Dec-2019 00000000000
JP-2019022522-A Method and apparatus for controlling moving speed of substance and utilization thereof Inactive 25-Oct-2018
JP-2018151397-A Single molecule recognition method, device, and program Inactive 01-May-2018 0
EP-3688449-A1 Nanoelectrode devices and methods of fabrication thereof Inactive 27-Sep-2017 00000000000
EP-3688449-A4 Nanoelectrode devices and methods of fabrication thereof Inactive 27-Sep-2017 G01N27/3276 0
To view Quantum Biosystems’s complete patent history, request access »

Quantum Biosystems FAQs

  • When was Quantum Biosystems founded?

    Quantum Biosystems was founded in 2013.

  • Who is the founder of Quantum Biosystems?

    Masateru Taniguchi Ph.D and Toshihiko Honkura are the founders of Quantum Biosystems.

  • Where is Quantum Biosystems headquartered?

    Quantum Biosystems is headquartered in Osaka, Japan.

  • What industry is Quantum Biosystems in?

    Quantum Biosystems’s primary industry is Biotechnology.

  • Is Quantum Biosystems a private or public company?

    Quantum Biosystems is a Private company.

  • What is Quantum Biosystems’s current revenue?

    The current revenue for Quantum Biosystems is 000000.

  • How much funding has Quantum Biosystems raised over time?

    Quantum Biosystems has raised $34.9M.

  • Who are Quantum Biosystems’s competitors?

    Personal Genome Diagnostics, Diagenode, Cellecta, Bionano, and Quantapore are some of the 33 competitors of Quantum Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »